New growth model
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
Kripa Mahalingam - July 26, 2019
Dr Reddy’s promoter GV Prasad buys in the open market amid growing headwind
Prathamesh Mulye - May 30, 2018
GV Prasad and Satish Reddy are continuing the legacy of Anji Reddy with a new blueprint to suit changing industry
N Mahalakshmi - July 29, 2015